Log in to save to my catalogue

Pharmaceutical Companies; Patent Issued for Treatment of Short Bowel Syndrome Patients with Colon-In...

Pharmaceutical Companies; Patent Issued for Treatment of Short Bowel Syndrome Patients with Colon-In...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1859821058

Pharmaceutical Companies; Patent Issued for Treatment of Short Bowel Syndrome Patients with Colon-In-Continuity (USPTO 9539310)

About this item

Full title

Pharmaceutical Companies; Patent Issued for Treatment of Short Bowel Syndrome Patients with Colon-In-Continuity (USPTO 9539310)

Publisher

Atlanta: NewsRx

Journal title

Medical Devices & Surgical Technology Week, 2017, p.315

Language

English

Publication information

Publisher

Atlanta: NewsRx

More information

Scope and Contents

Contents

According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by the inventors Sanguinetti, Elizabeth L. (Salt Lake City, UT); Marriott, Thomas B. (Sandy, UT); Lopansri, Jennifer (Park City, UT); Blosch, Consuelo M. (Seattle, WA), filed on October 5, 2016, was published online on January 10, 2017.

Alternative Titles

Full title

Pharmaceutical Companies; Patent Issued for Treatment of Short Bowel Syndrome Patients with Colon-In-Continuity (USPTO 9539310)

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_wirefeeds_1859821058

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1859821058

Other Identifiers

ISSN

1537-1409

E-ISSN

1537-1417

How to access this item